viru
discoveri
combin
sequenc
unbias
amplif
next
gener
sequenc
stateoftheart
previous
determin
perform
unbias
amplif
techniqu
oper
institut
virus
effici
respiratori
sampl
use
input
perform
assay
howev
known
clinic
materi
like
blood
stool
sampl
investig
sensit
fecessuspens
serum
sampl
posit
quantifi
noroviru
human
immunodefici
viru
type
respect
perform
serum
sampl
equal
perform
respiratori
materi
estim
lower
threshold
viral
genom
copi
estim
threshold
fecessuspens
around
viral
genom
copi
decreas
sensit
fece
suspens
mainli
due
sequenc
share
recogniz
ident
known
sequenc
like
sequenc
origin
bacteria
phage
complet
sequenc
discoveri
viral
pathogen
intensifi
last
decad
improv
molecular
method
sispa
random
prime
base
assay
univers
primer
represent
differ
analysi
introduct
high
throughput
sequenc
chanc
possibl
identifi
new
viru
increas
even
cost
per
nucleotid
sequenc
reduc
dramat
wherea
amount
data
retriev
singl
experi
increas
massiv
consequ
retriev
thousand
sequenc
read
singl
sampl
allow
theori
identif
viru
even
moder
low
viral
load
unbias
viru
discoveri
amplif
method
use
institut
vidisca
restrict
enzym
recognit
base
amplif
techniqu
allow
amplif
rna
dna
sequenc
regardless
genom
composit
pcr
product
vidisca
easili
sequenc
via
next
gener
sequenc
techniqu
adaptor
carri
necessari
tail
b
tail
ligat
vidisca
assay
allow
viru
amplif
respiratori
clinic
sampl
without
necess
cultur
read
respiratori
sampl
need
satisfactori
assay
sensit
howev
question
method
sensit
enough
clinic
materi
viru
hunt
identifi
novel
virus
involv
variou
diseas
exampl
undiagnos
diarrhea
kawasaki
diseas
perform
materi
respiratori
sampl
like
clinic
materi
differ
sampl
specif
background
eg
fece
contain
lot
bacteria
might
lead
reduc
amplif
viral
sequenc
therefor
necessari
determin
whether
viral
fragment
detect
nonrespiratori
clinic
sampl
studi
focus
perform
fecal
materi
serum
sampl
perform
fece
investig
use
broth
suspens
samplebank
collect
infect
individu
noroviru
infect
diagnos
five
peopl
via
real
time
rtpcr
viral
load
fece
suspens
rang
genom
copiesml
perform
describ
previous
respiratori
materi
thu
extra
purif
method
like
filtrat
perform
total
sequenc
obtain
five
patient
norovir
sequenc
sequenc
present
read
three
five
posit
patient
three
posit
sampl
viral
load
genom
copiesml
sequenc
norovirus
respect
percentag
shown
figur
two
sampl
neg
lower
copi
number
genom
copiesml
noroviru
sequenc
detect
read
respect
subsequ
background
sequenc
examin
determin
sourc
background
surprisingli
hardli
known
sequenc
act
main
competitor
read
nohit
nohit
sequenc
good
qualiti
averag
length
share
recogniz
homolog
known
sequenc
nonredund
ncbi
databas
remain
mainli
consist
bacteri
sequenc
probabl
origin
gut
microbiota
perform
vidisca
blood
product
investig
sera
human
immunodefici
viru
type
infect
person
n
viral
load
vari
mean
rna
copiesml
total
retriev
hiv
sequenc
sequenc
origin
sampl
sampl
detect
low
copi
number
rang
mean
rna
copiesml
wherea
posit
sampl
rang
viral
load
mean
plot
percentag
viral
hit
comparison
viral
load
shown
figur
illustr
trend
increas
percentag
viral
sequenc
higher
viral
load
comparison
relationship
viral
load
percentag
viral
sequenc
respiratori
materi
fecal
materi
also
includ
figur
observ
gener
serum
sampl
respiratori
sampl
perform
respiratori
materi
background
mainli
consist
human
ribosom
rna
rrna
serum
background
primarili
eukaryot
origin
probabl
origin
human
dna
sequenc
rrna
furthermor
substanti
amount
sequenc
detect
origin
vidisca
ingredi
vector
produc
enzym
etc
show
materi
rel
clean
requir
purif
exclud
possibl
vector
introduc
clinic
sampl
laboratori
sinc
encount
vector
never
use
respiratori
copancollect
swab
xaxi
viral
load
clinic
sampl
indic
yaxi
percentag
viral
sequenc
read
blood
noroviru
stool
coronavirus
adenovirus
picornavirus
influenzavirus
respiratori
materi
virus
percentag
respiratori
sampl
publish
previous
fecal
sampl
select
sampl
bank
contain
adult
patient
diarrhea
age
visit
outpati
clinic
academ
medic
center
year
fecal
sampl
suspend
broth
dilut
serum
sampl
infect
individu
obtain
amsterdam
cohort
studi
hiv
infect
aid
serum
sampl
select
base
posit
entri
amsterdam
cohort
studi
count
cellsmm
least
year
sinc
entri
amsterdam
cohort
studi
needl
share
like
risk
factor
infect
amsterdam
cohort
studi
conduct
accord
ethic
principl
set
declar
helsinki
written
inform
consent
obtain
prior
data
collect
studi
approv
amsterdam
medic
center
institut
medic
ethic
committe
atg
ttc
cgc
tgg
atg
cg
cgt
cct
tag
acg
cca
tca
tc
caa
gai
cci
atg
tti
agi
tgg
atg
ag
tcg
acg
cca
tct
tca
ttc
ac
minor
groov
bind
probe
tgg
aca
gga
gat
cgc
tgg
gag
ggc
gat
cg
assay
condit
describ
previous
cell
debri
bacteria
mitochondria
remov
fece
suspens
serum
centrifug
g
minut
residu
dna
degrad
u
turbo
tm
dnase
ambion
virionprotect
nucleic
acid
extract
boom
isol
elut
nucleic
acid
perform
steril
h
contain
rrnablock
oligonucleotid
see
revers
transcript
perform
describ
previous
follow
condit
revers
transcript
perform
superscript
ii
u
invitrogen
mixtur
contain
e
coli
ligas
u
invitrogen
nonrrna
bind
hexam
anchor
ligat
perform
anchor
base
primer
identifi
sequenc
mid
nt
see
gs
flx
shotgun
dna
librari
prepar
method
manual
anchor
contain
primer
b
total
differ
identifi
sequenc
use
allow
sampl
pool
one
region
picotiterpl
amplif
pcr
purif
product
emuls
pcr
perform
describ
sampl
run
region
picotiterpl
titanium
system
process
accord
emuls
small
volum
pcr
protocol
bead
per
emuls
input
small
volum
emuls
per
region
direct
titrat
protocol
read
assembl
use
codon
code
softwar
version
condoncod
corpor
dedham
usa
search
viral
sequenc
perform
blast
dutch
escienc
grid
ebioinfra
platform
blast
implement
take
sequenc
sff
fasta
format
perform
search
genbank
nonredund
nucleotid
databas
parallel
input
data
studi
use
genbank
build
follow
paramet
set
gapopen
gapextend
reward
evalu
everi
clinic
sampl
background
vidiscainterf
nonvir
nucleic
acid
respiratori
swab
determin
background
mainli
consist
rrna
introduc
sever
adjust
vidisca
protocol
select
enhanc
sequenc
everyth
differ
rrna
background
kind
materi
unknown
therefor
determin
perform
background
fece
suspens
serum
gener
serum
respiratori
materi
compar
detect
limit
approxim
copiesml
remark
background
serum
quit
differ
respiratori
materi
respiratori
materi
amount
ribosom
rna
serum
sampl
care
inspect
nonvir
sequenc
show
substanti
amount
sequenc
unassign
without
homolog
known
sequenc
serum
percentag
nohit
fecal
materi
high
amount
nohit
fece
could
attribut
high
number
bacteria
phage
materi
mani
fulli
sequenc
thu
read
remain
unassign
